Skip to main content

. 1983 Sep;48(3):437–440. doi: 10.1038/bjc.1983.210

Hepatocellular carcinoma and oral contraceptives.

B E Henderson, S Preston-Martin, H A Edmondson, R L Peters, M C Pike

PMCID: PMC2011476 PMID: 6311235

437

Images in this article

Figure 1
on p.439

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Baum J. K., Bookstein J. J., Holtz F., Klein E. W. Possible association between benign hepatomas and oral contraceptives. Lancet. 1973 Oct 27;2(7835):926–929. doi: 10.1016/s0140-6736(73)92594-4. [DOI] [PubMed] [Google Scholar]
Davis M., Portmann B., Searle M., Wright R., Williams R. Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br Med J. 1975 Nov 29;4(5995):496–498. doi: 10.1136/bmj.4.5995.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
Edmondson H. A., Henderson B., Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med. 1976 Feb 26;294(9):470–472. doi: 10.1056/NEJM197602262940904. [DOI] [PubMed] [Google Scholar]
Glassberg A. B., Rosenbaum E. H. Letter: Oral contraceptives and malignant hepatoma. Lancet. 1976 Feb 28;1(7957):479–479. doi: 10.1016/s0140-6736(76)91494-x. [DOI] [PubMed] [Google Scholar]
Mack T. M. Cancer surveillance program in Los Angeles County. Natl Cancer Inst Monogr. 1977 Dec;47:99–101. [PubMed] [Google Scholar]
Mays E. T., Christopherson W. M., Mahr M. M., Williams H. C. Hepatic changes in young women ingesting contraceptive steroids. Hepatic hemorrhage and primary hepatic tumors. JAMA. 1976 Feb 16;235(7):730–732. [PubMed] [Google Scholar]
Meyer P., LiVolsi V., Cornog J. L. Letter: Hepatoblastoma associated with an oral contraceptive. Lancet. 1974 Dec 7;2(7893):1387–1387. doi: 10.1016/s0140-6736(74)92259-4. [DOI] [PubMed] [Google Scholar]
O'Sullivan J. P., Rosswick R. P. Letter: Oral contraceptives and malignant hepatic tumours. Lancet. 1976 May 22;1(7969):1124–1125. doi: 10.1016/s0140-6736(76)99005-x. [DOI] [PubMed] [Google Scholar]
Pryor A. C., Cohen R. J., Goldman R. L. Hepatocellular carcinoma in a woman on long-term oral contraceptives. Cancer. 1977 Aug;40(2):884–888. doi: 10.1002/1097-0142(197708)40:2<884::aid-cncr2820400243>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
Rooks J. B., Ory H. W., Ishak K. G., Strauss L. T., Greenspan J. R., Hill A. P., Tyler C. W., Jr Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. 1979 Aug 17;242(7):644–648. [PubMed] [Google Scholar]
Tesluk H., Lawrie J. Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives. Arch Pathol Lab Med. 1981 Jun;105(6):296–299. [PubMed] [Google Scholar]
Thalassinos N. C., Lymberatos C., Hadjioannou J., Gardikas C. Letter: Liver-cell carcinoma after long-term oestrogen-like drugs. Lancet. 1974 Feb 16;1(7851):270–270. doi: 10.1016/s0140-6736(74)92579-3. [DOI] [PubMed] [Google Scholar]
Trias R., Rius X., Autonell J., Algaba F. Hepatocarcinoma and oral contraceptives. Lancet. 1978 Apr 15;1(8068):821–821. doi: 10.1016/s0140-6736(78)93017-9. [DOI] [PubMed] [Google Scholar]
Wanless I. R., Medline A. Role of estrogens as promoters of hepatic neoplasia. Lab Invest. 1982 Mar;46(3):313–320. [PubMed] [Google Scholar]
Yager J. D., Jr, Yager R. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res. 1980 Oct;40(10):3680–3685. [PubMed] [Google Scholar]

ACTIONS

RESOURCES